Colgate-Palmolive (COLPAL) Q2 FY27 India's Profit Lags Double-Digit Revenue Growth
The oral care leader posted a second straight quarter of double-digit sales growth, but aggressive marketing spend squeezed its net profit margin.
Colgate-Palmolive India's Q2 FY27 revenue grew 12.3% YoY, yet profit only inched up 4.3%. The gap highlights a margin squeeze from stepped-up advertising investments, even as premium toothpaste volumes surged.
For Colgate-Palmolive India, the story this quarter is a tale of two lines. The company delivered its second consecutive quarter of double-digit revenue growth, a clear sign of strong demand and market execution. Yet, the bottom line tells a different story, with profit growth lagging far behind as the company chose to reinvest heavily in its brands.
The numbers show the tension. Revenue rose 12.3% year-on-year to ₹1,705.79 crore. Profit after tax grew a more modest 4.3% to ₹341.57 crore. Sequentially, sales grew 6.4% while profit was nearly flat, dipping 0.4%. The net profit margin compressed to 20%, down 160 basis points from a year ago.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 1,705.79YoY +12% | 1,603.30 | 1,519.50 |
| Profit (₹ Cr) | 341.57YoY +4.3% | 343.08 | 327.51 |
| Net Profit Margin (%) | 20.0YoY -7.4% | 21.4 | 21.6 |
Where the growth came from
The robust revenue was driven by high-single-digit volume growth in the toothpaste portfolio, as reported by the company. Management highlighted strong performances in the premium range and the Colgate MaxFresh variant. This premiumisation push, where higher-value products grow faster, has been a key focus.
The cost of staying ahead
Why didn't this sales surge flow to the bottom line? The answer lies in stepped-up investments. Colgate's management stated it “further stepped up investments in brand building & premiumisation” this quarter. Reports from CNBC-TV18 and ScanX indicate advertising expenses jumped nearly 40% year-on-year, compressing the operating margin. The company is choosing to defend and grow its market leadership through spending, even as gross margins improved by 40 basis points.
Live Chart
· COLPAL
(BSE)
ISIN: INE259A01022
This strategy comes with a near-term trade-off. While the company’s “Funding the Growth” program is delivering cost savings, those benefits are being channeled back into the business. The outlook from management, as noted in their release, is to continue navigating commodity costs with “disciplined cost savings and calibrated pricing actions” while reinforcing growth with “strategic advertising investments.”
Key Points
- Colgate-Palmolive India reported a second straight quarter of double-digit revenue growth (12.3% YoY), led by strong premium toothpaste volumes.
- Profit growth of 4.3% significantly lagged revenue, causing the net profit margin to contract by 160 basis points to 20%.
- The margin pressure stemmed from a sharp increase in advertising and brand-building spend, as the company reinvested to fuel premiumisation and market leadership.
- The board declared a first interim dividend of ₹24 per share for FY27, amounting to a total payout of approximately ₹653 crore.
- Broker sentiment remains cautious, with a majority of analysts maintaining a 'Hold' rating, reflecting concerns over the growth-margin trade-off in a mature market.
Hexa Perspective
Colgate's quarter underscores the strategic pivot in a mature FMCG market: growth must be bought. The company is successfully driving volumes and premium mix, but the cost of that growth is now visible on the profit and loss statement. The critical question is how long this elevated investment phase lasts and when operating leverage might finally kick in. For now, the balance sheet remains a fortress with negligible debt, funding both aggressive marketing and generous dividends. Investors are weighing the durability of the volume-led growth against the persistence of margin pressure, in a category where competitive intensity shows no signs of easing.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.